Indef Manufacturing Limited (BOM:544364)

Blueprint Medicines Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025
Period Ending	Mar 31, 2025
Revenue	1,786
Cost of Revenue	952.31
Gross Profit	833.97
Selling, General & Admin	274.28
Other Operating Expenses	253.11
Operating Expenses	579.1
Operating Income	254.87
Interest Expense	-4.25
Interest & Investment Income	19.93
Currency Exchange Gain (Loss)	3.46
Other Non Operating Income (Expenses)	0.62
EBT Excluding Unusual Items	274.64
Gain (Loss) on Sale of Investments	145.07
Gain (Loss) on Sale of Assets	0.03
Asset Writedown	-0.79
Other Unusual Items	0.56
Pretax Income	419.51
Income Tax Expense	77.9
Net Income	341.6
Net Income to Common	341.6
Shares Outstanding (Basic)	32
Shares Outstanding (Diluted)	32
EPS (Basic)	10.68
EPS (Diluted)	10.68
Free Cash Flow	-39.71
Free Cash Flow Per Share	-1.24
Dividend Per Share	2.000
Gross Margin	46.69%
Operating Margin	14.27%
Profit Margin	19.12%
Free Cash Flow Margin	-2.22%
EBITDA	288.1
EBITDA Margin	16.13%
D&A For EBITDA	33.23
EBIT	254.87
EBIT Margin	14.27%
Effective Tax Rate	18.57%
Revenue as Reported	1,956
Advertising Expenses	32.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.